Avista is a contract development, manufacturing, and testing organization that aims to rapidly advance products through every stage of development. With over 200,000 square feet of laboratory and manufacturing space in the U.S. and UK, the company offers a broad suite of scientifically differentiated services ranging from early stage discovery, API and drug product development and cGMP manufacturing to stand-alone analytical and microbiology testing support. 

 

Earlier this year, Avista completed the acquisition of Solid Form Solutions, Ltd. located in Edinburgh, Scotland. The addition further expands Avista Pharma’s existing solid phase chemistry services and provides both companies’ customers access to a full suite of drug development services ranging from analytical development to API and drug product manufacturing.

 

For more information, please visit www.avistapharma.com.